Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +27.0% | +18.1% | 2 / 3 | -6.6% | -66.10 pp | +105.88 pp | +17.2% | -1.14 | — | 3,3 | −6,6% | −15,3 | +23,8% | — | -0.10 | — |
| Pts | 4 | 0 | 8 | 0 | 0 | 12 | 8 | 12 | 8 | |||||||
Valuation annotation:Price: 1.200 (close price on 2026-10-16)EPS (TTM): −2.601,7
Financial charts
1.Revenue & growth
VND bn3,27Q2/26
1.Revenue & growth
VND bn3,27Q2/26
2.Profit & growth
VND bn-15,1Q2/26
3.Profit mix (Penman)
VND bn-50,6Q2/26
4.Margins & cost structure
%12.5%Q2/26
5.Returns & cash cycle
% · days-9.2%Q2/26
Outlier warning: 5 period(s) outside -1.825…1.825 days, drawn at the limit
6.Earnings quality & cash
VND bn0,19Q2/26
7.Asset structure
VND bn230Q2/26
8.Funding & debt health
VND bn · times230Q2/26
9.Revenue backlog
VND bn0,16Q2/26
10.Valuation
times · %-0,6×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-757Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26